Operations and Summary of Significant Accounting Policies - Additional Information (Detail) $ / shares in Units, shares in Thousands		3 Months Ended	12 Months Ended
	Jun. 01, 2022 USD ($)	Dec. 31, 2022 USD ($) $ / shares	Dec. 31, 2022 USD ($) segment $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) $ / shares shares	Dec. 31, 2019 USD ($)
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Number of operating segments | segment			3
Accounts receivable from unconsolidated affiliate		$ 11,069,000	$ 11,069,000	$ 15,316,000
Partner funding recorded as reduction of selling and administrative expenses			128,153,000	103,447,000	$ 85,888,000
Advertising expense			88,667,000	66,375,000	60,865,000
Cumulative effect of adjustment from prior periods		$ 1,638,068,000	$ 1,638,068,000	$ 1,509,227,000	$ 1,342,429,000	$ 1,160,318,000
Basic (in dollars per share) | $ / shares		$ 2.24	$ 8.04	$ 6.27	$ 4.92
Diluted (in dollars per share) | $ / shares		$ 2.13	$ 7.66	$ 5.95	$ 4.87
Hanu
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Business combination, consideration transferred	$ 68,248,000
Business combination, contingent consideration, asset	8,501,000
Additional Paid-in Capital
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Cumulative effect of adjustment from prior periods		$ 327,872,000	$ 327,872,000	$ 368,282,000	$ 364,288,000	357,032,000
Retained Earnings
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Cumulative effect of adjustment from prior periods		$ 1,368,658,000	$ 1,368,658,000	1,167,690,000	$ 993,245,000	$ 841,097,000
Cumulative Effect, Period of Adoption, Adjustment
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Cumulative effect of adjustment from prior periods				(26,942,000)
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-in Capital
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Cumulative effect of adjustment from prior periods				(44,731,000)
Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Cumulative effect of adjustment from prior periods				$ 17,789,000
Restricted Stock Units (RSUs)
Organization Consolidation And Presentation Of Financial Statements [Line Items]
RSUs excluded from the diluted EPS calculations (in shares) | shares			39	2	122
Accounting Standards Update 2020-06
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Basic (in dollars per share) | $ / shares		$ (0.06)	$ (0.24)
Diluted (in dollars per share) | $ / shares		(0.06)	(0.22)
Maximum | Hanu
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Business combination, contingent consideration, liability	$ 20,000,000
Old Method of Accounting | Accounting Standards Update 2020-06
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Basic (in dollars per share) | $ / shares		2.18	7.80
Diluted (in dollars per share) | $ / shares		$ 2.07	$ 7.44
Customer Concentration Risk | Net Sales | Single Customer | Maximum
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Concentration percentage			10.00%
Partner Risk | Purchases | Microsoft
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Concentration percentage			22.00%
Partner Risk | Purchases | TD Synnex
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Concentration percentage			10.00%
Partner Risk | Purchases | Ingram Micro
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Concentration percentage			9.00%
Partner Risk | Purchases | Top Five Suppliers
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Concentration percentage			55.00%
Partner Risk | Purchases | Maximum | Significant Supplier
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Concentration percentage			10.00%